← back to search

Peter Lewindon

Second Military Medical University · CN
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Inflammatory Bowel Disease, Cystic Fibrosis Research Advances, Liver Disease and Transplantation, and Pediatric Hepatobiliary Diseases and Treatments.
h-index
38
citations
3,994
works
155
NIH funding
primary concept
Medicine
email

Recent publications

Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.
2023cited by 1position: contributordoi
Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis
Hepatology 2021cited by 1position: lastdoi
Predicting Outcomes in Pediatric Crohn’s Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease–Ahead Program
Gastroenterology 2020cited by 108position: middledoi
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease–Ahead Program
Gastroenterology 2020cited by 59position: middledoi
Normal liver stiffness and influencing factors in healthy children: An individual participant data meta‐analysis
Liver International 2020cited by 37position: middledoi
Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis
Clinical Gastroenterology and Hepatology 2019cited by 63position: firstdoi
Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study
Journal of Crohn s and Colitis 2018cited by 91position: middledoi
Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases
Alimentary Pharmacology & Therapeutics 2017cited by 275position: middledoi
Aspartate aminotransferase to platelet ratio and fibrosis‐4 as biomarkers in biopsy‐validated pediatric cystic fibrosis liver disease
Hepatology 2015cited by 109position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Grant A. Ramm · University of Queensland3 papers (2015–2020)Dan Turner · Oxford Nanopore Technologies (United Kingdom)2 papers (2020–2020)Daniel H. Leung · University of Oklahoma Health Sciences Center2 papers (2015–2019) · 2 papers (2015–2019)Dan Navon · Technion – Israel Institute of Technology2 papers (2020–2020)Amanda Ricciuto · University of Toronto2 papers (2020–2020)Thomas D. Walters · SickKids Foundation2 papers (2020–2020)M Aardoom · Erasmus MC - Sophia Children’s Hospital2 papers (2020–2020)Esther Orlanski‐Meyer · Shaare Zedek Medical Center2 papers (2020–2020)Víctor Manuel Navas‐López · Hospital Regional Universitario de Málaga2 papers (2020–2020)Marina Aloi · Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau2 papers (2020–2020)Nicholas Carman · University of Toronto2 papers (2020–2020)Séamus Hussey · Royal College of Surgeons in Ireland2 papers (2020–2020)Frank M. Ruemmele · Biodiversité et Biotechnologie Fongiques2 papers (2020–2020)Gábor Veres · University Hospital in Halle2 papers (2020–2020)Marina Orsi · Hospital Italiano de Buenos Aires2 papers (2020–2020)Jiří Bronský · Ospedale Papa Giovanni XXIII2 papers (2020–2020)Richard K. Russell · Centre for Inflammation Research2 papers (2020–2020)Anne M. Griffiths · SickKids Foundation2 papers (2020–2020)Lissy de Ridder · Erasmus MC - Sophia Children’s Hospital2 papers (2020–2020)